3D Tissue Models

Genomics: Case Western Reserve University

Total Score People Score Events Score
11 9 10
Date Event Presentation Speakers
May 22, 2014 Drug Discovery Summit Drug Discovery Summit Bryan Roth, Mahmoud Ghannoum
November 14, 2013 2013 PQG Conference - Emerging Quantitative Issues in Disease Epigenetics Multiple Enhancer Variants in Common Disease Peter Scacheri
April 6, 2013 AACR Annual Meetings Epigenetic Mechanisms of Cancer Risk Chairperson: Matthew L. Freedman, Dana-Farber Cancer Institute, Boston, MA Peter Scacheri
November 12, 2012 International Conference on Clinical Microbiology & Microbial Genomics Track 8: Current Topics in the Field of Medical Microbiology Menachem Shoham
March 5, 2010 The Future of Genomic Medicine III Will Missing Heritability be Filled in by Sequencing? Joseph Nadeau
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis Molecular Synergy of Driver Genes in Colon Cancer Mark Chance
May 18, 2008 COMPUTATIONAL ASPECTS - BIOMOLECULAR NMR Using an ensemble approach in the refinement of an NMR derived structure. Comparison with the x-ray structure and molecular dynamics calculations Matthias Buck
February 19, 2008 Cancer Genomics and Epigenomics RNA and Functional Screening Gregory J. Hannon
January 20, 2008 PROTEIN COFACTORS, RADICALS AND QUINONES Distal structural features controlling substrate and mechanism-based inhibitor selectivity in copper amine oxidases Lawrence Sayre
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY (08:30-16:00) Mark Chance
Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY: Redefining Biomarkers for Diabetes and Diabetic Complications: A Systems Biology Approach (12:00-12:30) Mark Chance
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.